A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
CURIS INC
CRIS
$192M
Mkt Cap
$4.89
+4.71%
CURIS INC (CRIS) has a 5-year average return on invested capital (ROIC) of -71.7%. This is below average and may indicate limited pricing power.
CURIS INC (CRIS) has a market capitalization of $192M. It is classified as a small-cap stock.
CURIS INC (CRIS) does not currently pay a regular dividend.
CURIS INC (CRIS) operates in the Biological Products, (No Diagnostic Substances) industry, within the Healthcare sector.
CURIS INC (CRIS) reported annual revenue of $9 million in its most recent fiscal year, based on SEC EDGAR filings.
CURIS INC (CRIS) has a net profit margin of -80.3%. The company is currently unprofitable.
CURIS INC (CRIS) generated $-27 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Table of Contents We will require substantial funds to maintain our research and development program and support operations in the near term. We have incurred losses and negative cash flows from operations since our inception. As of December 31, 2024, we had $20.0 million in cash and cash equivalents. In March 2025, we completed a registered direct offering and concurrent private placement for net proceeds of approximately $9.0 million. We expect these available cash resources, together with the proceeds from the March 2025 offering, to fund our existing operations into the fourth quarter of 2025. We have based this assessment on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. We will require substantial additional funding in the immediate term to fund the development of emavusertib through regulatory approval and commercialization, and to support our continued operations.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 9.4M | 9.4M | - | - | - | - |
| Net Income | -7.6M | -7.6M | -43M | -47M | -57M | -45M |
| EPS | $-0.19 | $-0.19 | $-2.29 | $-2.99 | $-80.93 | $-3.31 |
| Free Cash Flow | -27M | -27M | -40M | -38M | -55M | -38M |
| ROIC | -223.5% | -22.6% | -85.3% | -126.9% | -82.6% | -40.9% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.30 | 0.30 | -3.01 | 1.01 | 0.08 | 0.06 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | -5.7M | -5.7M | -45M | -48M | -53M | -42M |
| Operating Margin | -60.5% | -60.5% | - | - | - | - |
| ROE | -138.8% | -138.8% | - | -143.2% | -82.6% | -41.0% |
| Shares Outstanding | 39M | 39M | 19M | 16M | 1M | 14M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 9.8M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 9.4M | 9.4M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | 14M | 27M | 18M | 45M | 24M | 22M | 23M | 35M | 43M | 39M | 39M | 28M | 28M |
| SG&A | 12M | 13M | 16M | 14M | 15M | 12M | 12M | 17M | 20M | 19M | 17M | 14M | 14M |
| EBIT | -16M | -56M | -58M | -50M | -29M | -24M | -25M | -42M | -53M | -48M | -45M | -5.7M | -5.7M |
| Op. Margin | -161.2% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -60.5% | -60.5% |
| Net Income | -19M | -59M | -60M | -53M | -33M | -32M | -30M | -45M | -57M | -47M | -43M | -7.6M | -7.6M |
| Net Margin | -190.3% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -80.3% | -80.3% |
| Non-Recurring | 2K | 22K | 0 | 0 | 293K | 271K | -24K | 0 | 0 | 0 | 0 | 27M | 27M |
| Returns on Capital | |||||||||||||
| ROIC | -29.8% | -86.5% | -94.1% | -102.5% | -77.8% | -69.4% | -61.5% | -40.9% | -82.6% | -126.9% | -85.3% | -22.6% | N/M |
| ROE | -50.0% | -125.1% | -128.6% | -199.5% | -334.2% | 167.4% | -61.8% | -41.0% | -82.6% | -143.2% | N/A | -138.8% | -138.8% |
| ROA | -26.2% | -74.9% | -79.1% | -81.1% | -58.6% | -88.7% | -25.0% | -24.8% | -41.8% | -50.9% | -73.2% | -24.8% | -38.0% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -17M | -30M | -36M | -48M | -30M | -26M | -26M | -38M | -54M | -38M | -40M | -27M | -27M |
| Free Cash Flow | -17M | -30M | -36M | -49M | -30M | -26M | -26M | -38M | -55M | -38M | -40M | -27M | -27M |
| Owner Earnings | -20M | -34M | -40M | -54M | -34M | -29M | -29M | -43M | -61M | -45M | -46M | -31M | -31M |
| CapEx | 92K | 48K | 329K | 188K | 85K | 41K | 677K | 0 | 416K | 0 | 0 | 0 | 0 |
| Maint. CapEx | 155K | 161K | 193K | 235K | 177K | 125K | 144K | 158K | 233K | 255K | 203K | 169K | 169K |
| Growth CapEx | 0 | 0 | 136K | 0 | 0 | 0 | 533K | N/A | 183K | N/A | N/A | N/A | 0 |
| D&A | 155K | 161K | 193K | 235K | 177K | 125K | 144K | 158K | 233K | 255K | 203K | 169K | 169K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 3.1M | 3.9M | 4.3M | 5.4M | 3.9M | 2.7M | 2.7M | 5.3M | 6.8M | 6.0M | 5.9M | 4.0M | 4.0M |
| Debt Repayment | 1.6M | 4.2M | 4.3M | 5.0M | 6.1M | 1.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | -21M | -58M | -25M | -19M | 11M | -20M | -161M | -111M | -82M | -37M | -1.9M | -8.5M | -3.4M |
| Cash & Equiv. | 7.7M | 33M | 26M | 38M | 24M | 15M | 130M | 40M | 20M | 27M | 20M | 5.1M | 5.1M |
| Long-Term Debt | 23M | 20M | 15M | 36M | 29M | 0 | 557K | 0 | N/A | 8.5M | 7.6M | 0 | N/A |
| Debt/Equity | 0.95 | 0.37 | 0.67 | 1.73 | -7.89 | -0.00 | 0.06 | 0.06 | 0.08 | 1.01 | -3.01 | 0.30 | 0.30 |
| Interest Coverage | -4.2 | -17.0 | -20.9 | -12.5 | -7.5 | -30.8 | N/A | N/A | -12.9 | -20.5 | -96.6 | -3.7 | -3.7 |
| Equity | 30M | 65M | 29M | 24M | -4.5M | -34M | 131M | 91M | 47M | 20M | -6.0M | 5.5M | 5.5M |
| Total Assets | 63M | 95M | 58M | 74M | 37M | 35M | 204M | 162M | 109M | 77M | 41M | 20M | 20M |
| Total Liabilities | 33M | 30M | 28M | 50M | 42M | 69M | 74M | 72M | 62M | 58M | 47M | 15M | 15M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 0 |
| Retained Earnings | -780M | -839M | -899M | -952M | -985M | -1.0B | -1.0B | -1.1B | -1.1B | -1.2B | -1.2B | -1.2B | -1.2B |
| Working Capital | 42M | 75M | 35M | 50M | 15M | 18M | 163M | 109M | 82M | 39M | 7.4M | -7.2M | -7.2M |
| Current Assets | 52M | 86M | 48M | 64M | 28M | 25M | 173M | 122M | 92M | 61M | 26M | 6.9M | 6.9M |
| Current Liabilities | 10M | 11M | 14M | 14M | 13M | 6.5M | 10M | 13M | 10M | 22M | 19M | 14M | 14M |
| Per Share Data | |||||||||||||
| EPS | -7.33 | -16.00 | -15.00 | -59.67 | -6.53 | -6.47 | -4.07 | -3.31 | -80.93 | -2.99 | -2.29 | -0.19 | -0.19 |
| Owner EPS | -7.84 | -9.20 | -10.01 | -60.37 | -6.86 | -5.83 | -3.89 | -3.13 | -87.57 | -2.82 | -2.42 | -0.80 | -0.80 |
| Book Value | 11.66 | 17.50 | 7.31 | 26.85 | -0.90 | -6.82 | 17.77 | 6.60 | 66.48 | 1.24 | -0.32 | 0.14 | 0.14 |
| Cash Flow/Share | -6.58 | -8.11 | -8.89 | -54.11 | -6.03 | -5.27 | -3.50 | -2.74 | -77.60 | -2.42 | -2.09 | -0.69 | -0.19 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 2.6M | 3.7M | 4.0M | 0.9M | 5.0M | 5.0M | 7.4M | 13.7M | 0.7M | 15.9M | 18.9M | 39.2M | 39.2M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 195.2 | N/A | N/A | N/A | N/A | -25.3 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 73.7 | 108.6 | 290.8 | 90.6 | N/A | N/A | 59.1 | 104.0 | 1.0 | 3.7 | N/A | N/A | 35.1 |
| Price/Sales | 347.8 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 20.3 |
| FCF Yield | -0.8% | -0.4% | -0.4% | -2.2% | -6.0% | -2.6% | -0.3% | -0.4% | -119.7% | -52.3% | -193.0% | N/A | -14.2% |
| Market Cap | 2.2B | 7.0B | 8.5B | 2.2B | 505M | 1.0B | 7.7B | 9.4B | 46M | 74M | 20M | 0 | 192M |
| Avg. Price | 201.09 | 265.58 | 207.91 | 198.87 | 44.35 | 34.38 | 30.76 | 177.61 | 30.94 | 12.54 | 8.29 | 0.00 | 4.89 |
| Year-End Price | 129.00 | 285.00 | 317.00 | 73.00 | 15.20 | 31.00 | 157.60 | 97.60 | 9.80 | 13.89 | 3.25 | 0.00 | 4.89 |
CURIS INC passes 0 of 9 quality checks, indicating weak fundamentals.
CURIS INC (CRIS) has a debt-to-equity ratio of 0.30. This indicates a conservatively financed balance sheet.
CURIS INC (CRIS) reported earnings per share (EPS) of $-0.19 in its most recent fiscal year.
CURIS INC (CRIS) has a return on equity (ROE) of -138.8%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 17 years of financial data for CURIS INC (CRIS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
CURIS INC (CRIS) has a book value per share of $0.14, based on its most recent annual SEC filing.